Want to see HK:3613 full AI Analyst Report?
Earnings Data
Report Date
Aug 07, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
0.28Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) Earnings, Revenues Date & History
HK:3613 Q4 2025 Earnings Report
HK:3613 Upcoming Earnings
Beijing Tong Ren Tang Chinese Medicine Co's next earnings date is estimated for August 7, 2026, based on past reporting schedules.
HK:3613 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:3613 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 20, 2026 | HK$7.98 | HK$7.83 | -1.89% |
Aug 22, 2025 | HK$8.76 | HK$8.66 | -1.18% |
Mar 28, 2025 | HK$7.85 | HK$7.92 | +0.81% |
Aug 30, 2024 | HK$7.65 | HK$7.66 | +0.12% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613) report earnings?
Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613) is schdueled to report earning on Aug 07, 2026, TBA (Confirmed).
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613) earnings time?
Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613) earnings time is at Aug 07, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Beijing Tong Ren Tang Chinese Medicine Co Ltd stock?
The P/E ratio of Beijing Tong Ren Tang Chinese Medicine Co is N/A.
What is HK:3613 EPS forecast?
Currently, no data Available